Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Saved in:
| Title: | Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. |
|---|---|
| Authors: | Cohen SB (AUTHOR), Emery P (AUTHOR), Greenwald MW (AUTHOR), Dougados M (AUTHOR), Furie RA (AUTHOR), Genovese MC (AUTHOR), Keystone EC (AUTHOR), Loveless JE (AUTHOR), Burmester G (AUTHOR), Cravets MW (AUTHOR), Hessey EW (AUTHOR), Shaw T (AUTHOR), Totoritis MC (AUTHOR), REFLEX Trial Group (CORPORATE AUTHOR) |
| Source: | Arthritis & Rheumatism. Sep2006, Vol. 54 Issue 9, p2793-2806. 14p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 106138336 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Cohen+SB%22">Cohen SB</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Emery+P%22">Emery P</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Greenwald+MW%22">Greenwald MW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dougados+M%22">Dougados M</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Furie+RA%22">Furie RA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Genovese+MC%22">Genovese MC</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keystone+EC%22">Keystone EC</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Loveless+JE%22">Loveless JE</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burmester+G%22">Burmester G</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cravets+MW%22">Cravets MW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hessey+EW%22">Hessey EW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shaw+T%22">Shaw T</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Totoritis+MC%22">Totoritis MC</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22REFLEX+Trial+Group%22">REFLEX Trial Group</searchLink> (CORPORATE AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Arthritis+%26+Rheumatism%22">Arthritis & Rheumatism</searchLink>. Sep2006, Vol. 54 Issue 9, p2793-2806. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=106138336 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/art.22025 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 2793 Titles: – TitleFull: Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cohen SB – PersonEntity: Name: NameFull: Emery P – PersonEntity: Name: NameFull: Greenwald MW – PersonEntity: Name: NameFull: Dougados M – PersonEntity: Name: NameFull: Furie RA – PersonEntity: Name: NameFull: Genovese MC – PersonEntity: Name: NameFull: Keystone EC – PersonEntity: Name: NameFull: Loveless JE – PersonEntity: Name: NameFull: Burmester G – PersonEntity: Name: NameFull: Cravets MW – PersonEntity: Name: NameFull: Hessey EW – PersonEntity: Name: NameFull: Shaw T – PersonEntity: Name: NameFull: Totoritis MC – PersonEntity: Name: NameFull: REFLEX Trial Group IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: Sep2006 Type: published Y: 2006 Identifiers: – Type: issn-print Value: 00043591 Numbering: – Type: volume Value: 54 – Type: issue Value: 9 Titles: – TitleFull: Arthritis & Rheumatism Type: main |
| ResultId | 1 |